Recently Added |View All
Video
Richard Van Etten, MD, PhD shares a year of advancements in cancer care
UCI Medical Center is committed to excellence and research in cancer care.
News
UCI Health physician recognized by the Society of Surgical Oncology
Oliver Eng, MD has received the prestigious Lisa Kurtz Luciano Appendix Cancer and Pseudomyxoma Peritonei Clinical Investigator Award.
News
Young dancer triumphs over rare pancreatic tumor
A CT scan at Children's Hospital of Orange revealed a mass on her pancreas, leading to a referral to UCI Health Chao Digestive Health Institute.
News
Internationally renowned UCI Health hematologist-oncologist Dr. Susan O’Brien has been honored with the Excellence in Scientific Service Award by the Leukemia & Lymphoma Society for her vast contributions to the field.
News
Thoracic Surgeon, Ali Mahtabifard, MD, Treats Musician Who is Now Cancer-Free
"Dr. Mahtabifard is my hero," said Green Day's Jason Freese after beating lung cancer.
News
Targeted therapy a game changer for metastatic breast cancer
Mohammadbagher Ziari, MD, used olaparib to successfully treat a patient's metastatic breast cancer which is now in remission.
Video
Advanced care enabled by seamless collaboration
Cutting-edge technology integrated with a team-based approach, allows UCI Health to deliver precise treatment quickly and effectively.
Video
Stereotactic radiosurgery (SRS) at UCI Health
These noninvasive treatments target even the smallest, hardest-to-reach tumors with sub-millimeter precision.
Video
Head and neck oncologist discusses advanced treatment paradigms presented at ASCO 2024
Hear why attending this meeting improves her ability to care for patients with metastatic disease.
Video
Tumor immunologist discusses 2024 ASCO Annual Meeting late-breaking news
Nelson provides specialized care in blood disorders, hematology oncology, and medical oncology.
Video
Survey of actionable driver mutations KRAS and EGFR in non–small cell lung cancer
Molecularly targeted therapies have advanced treatment for certain cancers, such as lung cancer with specific EGFR or KRAS mutations. However, oftentimes the tumor becomes eventually treatment resistant.
Video
Next-generation testing in patients with non-small cell lung cancer
Tumor sequencing at the time of progression, whether tissue or liquid biopsy, is important to identify the mechanism of resistance.
